Melanotan 2 (MT-2)

🔹 What is MT-2?

Class: Synthetic melanocortin peptide analog (shorter chain version of α-MSH). Mechanism:

• Potent agonist at MC1R (melanocortin-1 receptor) → stimulates melanin production → deep, UV-independent tanning.
• Also activates MC3R/MC4R → influences appetite regulation, metabolism, and sexual arousal/libido.
• Compared to MT-1, MT-2 is stronger, longer-lasting, and has more systemic effects beyond pigmentation.

Primary focus:

• Darker and longer-lasting tanning than MT-1.
• Libido enhancement (“PT-141–like” effect, since MT-2 is the parent compound).
• Appetite and energy regulation via melanocortin pathway.

Molecular profile: MT-2 is a cyclic, truncated version of Melanotan I. MW 1024.18 Daltons. Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2.

Why MT-2 does what MT-1 doesn’t: Unlike MT-1, MT-2 crosses the blood-brain barrier, which is exactly why it produces central effects MT-1 lacks—libido enhancement, improved erectile function in men, and appetite/metabolic effects (appetite suppression, support for glucose and lipid homeostasis).

Additional applications: Improves vitiligo; may help with opiate and ethanol addiction by acting on melanocortin pathways that reduce opiate tolerance and ethanol consumption; supports ischemic disease and circulatory shock via vagus nerve stimulation (the cholinergic anti-inflammatory pathway); shows neuroprotective and anti-inflammatory effects.

Compared to PT-141: MT-2 desensitizes less than PT-141 with regular use, and its sexual-stimulation effect tends to build gradually over long-term use rather than hitting acutely like PT-141.

---

🔹 Oral Dosage: Not effective; degraded in the GI tract.

---

🔹 Injectable / Subcutaneous Dosage (most common) Range:

• Loading phase: 0.25–0.5 mg daily or every other day for 1–2 weeks.
• Maintenance phase: 0.5–1 mg 2–3x per week (sometimes less, depending on tan depth).

Frequency: Subcutaneous injections, rotating sites. Rationale: Small microgram doses are sufficient; higher frequency front-loads pigmentation, then lower doses sustain it.

---

🔹 Cycle Length

• Loading phase: 1–2 weeks until desired pigmentation develops.
• Maintenance phase: Weeks to months (0.5–1 mg 2–3x/week).
• Breaks can be taken if pigmentation is sustained without further dosing.

---

🔹 Optimal Dosing Window

• Evening dosing is preferred since MT-2 can cause nausea, flushing, or appetite suppression shortly after injection.
• Some pair injections with UV/sun exposure to amplify tanning.

---

✅ Educational Integration Example

• Example protocol: 0.25 mg MT-2 daily for 10 days, followed by 0.5 mg 2–3x/week for 8 weeks.
• Alternate tanning protocol: 200mcg SubQ daily during week 1, then once pigment stabilizes, 100mcg SubQ twice weekly (can taper to 50mcg depending on desired pigment level).
• Lifestyle pairing: Moderate UV exposure, hydration, antioxidant skin support.

---

🔹 Stacking Strategy (Educational / Complementary) Since MT-2 affects pigmentation, libido, and appetite/metabolism, stacks often focus on: 🔸 Skin & Repair Support:

• GH secretagogues (CJC-1295/Ipamorelin), GHK-Cu, BPC-157: Promote skin elasticity and healing.
• Antioxidants (Vitamin C, NAC, CoQ10): Counter oxidative stress from UV exposure.

🔸 Sexual Health:

• PT-141 (Bremelanotide): For more targeted libido effects without tanning.
• Arginine, Citrulline, L-Carnitine: Support vascular function and performance.

🔸 Metabolic/Weight Management:

• GLP-1 agonists (Tirzepatide/Retatrutide) or L-Carnitine: Complement appetite-modulating effects.

Rationale: MT-2 is broader acting than MT-1, so stacks emphasize skin health, oxidative protection, sexual wellness, and metabolic synergy without duplicating melanocortin receptor activation.

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.